{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:35:05Z","timestamp":1781706905136,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This research has been funded by Scientific Research Deanship at University of Ha\u2019il\u2011Saudi Arabia","award":["RG\u201123 131"],"award-info":[{"award-number":["RG\u201123 131"]}]},{"name":"This research has been funded by Scientific Research Deanship at University of Ha\u2019il\u2011Saudi Arabia","award":["RG\u201123 131"],"award-info":[{"award-number":["RG\u201123 131"]}]},{"name":"This research has been funded by Scientific Research Deanship at University of Ha\u2019il\u2011Saudi Arabia","award":["RG\u201123 131"],"award-info":[{"award-number":["RG\u201123 131"]}]},{"name":"This research has been funded by Scientific Research Deanship at University of Ha\u2019il\u2011Saudi Arabia","award":["RG\u201123 131"],"award-info":[{"award-number":["RG\u201123 131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79688-2","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T12:05:53Z","timestamp":1732190753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["LATS2 and FAT4 as key candidate genes of hippo pathway associated with the risk and progression of breast cancer: an in-silico approach"],"prefix":"10.1038","volume":"14","author":[{"family":"Sadaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashir","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheersh","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz A","family":"Aloliqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik Asif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"79688_CR1","unstructured":"https:\/\/www.wcrf.org\/cancer-trends\/"},{"issue":"2","key":"79688_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/ijms22020636","volume":"22","author":"HJ Wu","year":"2021","unstructured":"Wu, H. J. & Chu, P. Y. Recent discoveries of Macromolecule- and cell-based biomarkers and therapeutic implications in breast Cancer. Ijms. 22 (2), 636. https:\/\/doi.org\/10.3390\/ijms22020636 (2021).","journal-title":"Ijms"},{"issue":"1","key":"79688_CR3","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41467-021-23271-0","volume":"12","author":"NB Punturi","year":"2021","unstructured":"Punturi, N. B. et al. Mismatch repair deficiency predicts response to HER2 blockade in HER2- negative breast cancer. Nat. Commun. 12 (1), 2940. https:\/\/doi.org\/10.1038\/s41467-021-23271-0 (2021).","journal-title":"Nat. Commun."},{"issue":"22","key":"79688_CR4","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.3390\/cells11223545","volume":"11","author":"K Venetis","year":"2022","unstructured":"Venetis, K. et al. Analytical performance of next-generation sequencing and RT-PCR on formalinfixed paraffin-embedded tumor tissues for PIK3CA testing in HR+\/HER2\u2009\u2013\u2009breast cancer. Cells. 11 (22), 3545. https:\/\/doi.org\/10.3390\/cells11223545 (2022).","journal-title":"Cells"},{"key":"79688_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1001\/jamaoncol.2022.2286","volume":"8","author":"P Tarantino","year":"2022","unstructured":"Tarantino, P. et al. Prognostic and biologic significance of ERBB2-low expression in early-stage breast cancer. JAMA Oncol. 8, 1177\u20131183. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2286 (2022).","journal-title":"JAMA Oncol."},{"issue":"0","key":"79688_CR6","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1200\/jco.22.01063","volume":"022","author":"NL Henry","year":"2022","unstructured":"Henry, N. L. et al. Biomarkers for systemic therapy in metastatic breast cancer: ASCO guideline update. J. Clin. Oncol. 022 (0), 3205\u20133221. https:\/\/doi.org\/10.1200\/jco.22 (2022).","journal-title":"J. Clin. Oncol."},{"key":"79688_CR7","doi-asserted-by":"crossref","unstructured":"Guimei, M. et al. Inhibition of yes-associated protein-1 (YAP1) enhances the response of invasive breast cancer cells to the standard therapy. Breast Cancer: Targets Therapy, pp.189\u2013199. (2020).","DOI":"10.2147\/BCTT.S268926"},{"key":"79688_CR8","doi-asserted-by":"crossref","unstructured":"Skibinski, A. et al. Joshua LaBaer, and Charlotte Kuperwasser. The Hippo transducer TAZ interacts with the SWI\/SNF complex to regulate breast epithelial lineage commitment. Cell reports 6, no. 6 : 1059\u20131072. (2014).","DOI":"10.1016\/j.celrep.2014.02.038"},{"key":"79688_CR9","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s13277-013-0895-8","volume":"34","author":"X Lin","year":"2013","unstructured":"Lin, X., Cai, F., Li, X. & Kong, X. Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer. Tumor Biol. 34, 3239\u20133243 (2013).","journal-title":"Tumor Biol."},{"issue":"5","key":"79688_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/cells8050426","volume":"8","author":"J Luo","year":"2019","unstructured":"Luo, J. & Yu, F. X. GPCR-Hippo signaling in cancer. Cells. 8 (5), 426 (2019).","journal-title":"Cells"},{"key":"79688_CR11","doi-asserted-by":"crossref","unstructured":"Vici, P. et al. The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy. Oncotarget 5, no. 20 : 9619. (2014).","DOI":"10.18632\/oncotarget.2449"},{"issue":"5","key":"79688_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.trecan.2019.04.001","volume":"5","author":"PC Calses","year":"2019","unstructured":"Calses, P. C., Crawford, J. J., Lill, J. R. & Dey, A. Hippo pathway in cancer: aberrant regulation and therapeutic opportunities. Trends cancer. 5 (5), 297\u2013307 (2019).","journal-title":"Trends cancer"},{"key":"79688_CR13","doi-asserted-by":"publisher","first-page":"10623","DOI":"10.1038\/s41598-018-28928-3","volume":"8","author":"AM Poma","year":"2018","unstructured":"Poma, A. M. et al. Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature. Sci. Rep. 8, 10623 (2018).","journal-title":"Sci. Rep."},{"issue":"W1","key":"79688_CR14","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profling and interactive analyses. Nucleic Acids Res. 45 (W1), W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"79688_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorfy","year":"2010","unstructured":"Gyorfy, B. et al. An online survival analysis tool to rapidly assess the efect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123 (3), 725\u2013731 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"79688_CR16","doi-asserted-by":"crossref","unstructured":"Lanczky, A. & Gyorfy, B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J. Med. Internet Res. 23(7), e27633 (2021).","DOI":"10.2196\/27633"},{"issue":"Database issue","key":"79688_CR17","doi-asserted-by":"publisher","first-page":"D562","DOI":"10.1093\/nar\/gki022","volume":"33","author":"T Barrett","year":"2005","unstructured":"Barrett, T. et al. NCBI GEO: mining millions of expression profles\u2013database and tools. Nucleic Acids Res. 33 (Database issue), D562\u2013D563 (2005).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"79688_CR18","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou, G. et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 47 (W1), W234\u2013W241 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"79688_CR19","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infltrating immune cells. Nucleic Acids Res. 48 (W1), W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"79688_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur, V. et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 10 (3), 277\u2013288 (2018).","journal-title":"Epigenomics"},{"key":"79688_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-0716-2095-3_2","volume":"2449","author":"P Porras","year":"2022","unstructured":"Porras, P., Orchard, S. & Licata, L. IMEx databases: displaying molecular interactions into a single, standards-compliant dataset. Methods Mol. Biol. 2449, 27\u201342 (2022).","journal-title":"Methods Mol. Biol."},{"key":"79688_CR22","unstructured":"World Health Organization. (2022)."},{"key":"79688_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-015-0560-9","volume":"17","author":"A Toss","year":"2015","unstructured":"Toss, A. & Cristofanilli, M. Molecular characterization and targeted therapeutic approaches in breast cancer. Breast Cancer Res. 17, 1\u201311 (2015).","journal-title":"Breast Cancer Res."},{"issue":"3","key":"79688_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/BIB\/BBX158","volume":"20","author":"Y Lin","year":"2019","unstructured":"Lin, Y. et al. Computer-aided biomarker discovery for precision medicine: data resources, models and applications. Brief. Bioinform. 20 (3), 952\u2013975. https:\/\/doi.org\/10.1093\/BIB\/BBX158 (2019).","journal-title":"Brief. Bioinform."},{"issue":"JUL","key":"79688_CR25","doi-asserted-by":"publisher","first-page":"465362","DOI":"10.3389\/FGENE.2019.00695\/BIBTEX","volume":"10","author":"JL Deng","year":"2019","unstructured":"Deng, J. L., Xu, Y. H. & Wang, G. Identification of potential crucial genes and key pathways in breast cancer using bioinformatic analysis. Front. Genet. 10 (JUL), 465362. https:\/\/doi.org\/10.3389\/FGENE.2019.00695\/BIBTEX (2019).","journal-title":"Front. Genet."},{"key":"79688_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.gene.2018.07.033","volume":"676","author":"HM Sadaf","year":"2018","unstructured":"Sadaf, H. M. et al. Hypermethylated LATS2 gene with decreased expression in female breast cancer: a case control study from North India. Gene. 676, 156\u2013163 (2018). Epub 2018 Jul 17. PMID: 30010037.","journal-title":"Gene"},{"issue":"2","key":"79688_CR27","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3892\/ol.2017.7535","volume":"15","author":"S Matsui","year":"2018","unstructured":"Matsui, S. et al. LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer. Oncol. Lett. 15 (2), 2595\u20132603. https:\/\/doi.org\/10.3892\/ol.2017.7535 (2018). Epub 2017 Dec 6. PMID: 29434979; PMCID: PMC5777308.","journal-title":"Oncol. Lett."},{"key":"79688_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega, F. et al. Oncogenic signaling pathways in the Cancer Genome Atlas. Cell. 173, 321\u2013337e10 (2018).","journal-title":"Cell"},{"issue":"7848","key":"79688_CR29","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/s41586-020-03131-5","volume":"591","author":"S Ma","year":"2021","unstructured":"Ma, S. et al. Hippo signalling maintains ER expression and ER\u2009+\u2009breast cancer growth. Nature. 591 (7848), E1\u2013E0 (2021).","journal-title":"Nature"},{"key":"79688_CR30","doi-asserted-by":"publisher","first-page":"105723","DOI":"10.1016\/j.phrs.2021.105723","volume":"170","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. The novel FAT4 activator jujuboside a suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation. Pharmacol. Res. 170, 105723 (2021). Epub 2021 Jun 9. PMID: 34116210.","journal-title":"Pharmacol. Res."},{"issue":"4","key":"79688_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/ijc.23775","volume":"124","author":"C Qi","year":"2009","unstructured":"Qi, C., Zhu, Y. T., Hu, L. & Zhu, Y. J. Identification of FAT4 as a candidate tumor suppressor gene in breast cancers. Int. J. Cancer. 124 (4), 793\u2013798. https:\/\/doi.org\/10.1002\/ijc.23775 (2009). PMID: 19048595; PMCID: PMC2667156.","journal-title":"Int. J. Cancer"},{"issue":"4","key":"79688_CR32","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1158\/1078-0432.CCR-04-1773","volume":"11","author":"Y Takahashi","year":"2005","unstructured":"Takahashi, Y. et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin. Cancer Res. 11 (4), 1380\u20131385 (2005).","journal-title":"Clin. Cancer Res."},{"key":"79688_CR33","doi-asserted-by":"publisher","first-page":"586581","DOI":"10.3389\/fcell.2020.586581","volume":"8","author":"Y Gu","year":"2020","unstructured":"Gu, Y. et al. Hypermethylation of LATS2 promoter and its prognostic value in IDH-mutated low-grade gliomas. Front. Cell. Dev. Biology. 8, 586581 (2020).","journal-title":"Front. Cell. Dev. Biology"},{"key":"79688_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-10-538","volume":"10","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis. BMC cancer. 10, 1\u20133 (2010).","journal-title":"BMC cancer"},{"issue":"4","key":"79688_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/gcc.2870140402","volume":"14","author":"I Bi\u00e8che","year":"1995","unstructured":"Bi\u00e8che, I. & Lidereau, R. Genetic alterations in breast cancer. Genes Chromosom. Cancer. 14 (4), 227\u2013251 (1995).","journal-title":"Genes Chromosom. Cancer"},{"issue":"3","key":"79688_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.lungcan.2008.09.011","volume":"64","author":"M Stra\u017ei\u0161ar","year":"2009","unstructured":"Stra\u017ei\u0161ar, M., Mlakar, V., Damjan & Glava\u010d LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma. Lung cancer. 64 (3), 257\u2013262 (2009).","journal-title":"Lung cancer"},{"key":"79688_CR37","doi-asserted-by":"crossref","unstructured":"Li, J. J., Julia, Y. & Tsang and Gary M. Tse. Tumor microenvironment in breast cancer\u2014updates on therapeutic implications and pathologic assessment. Cancers 13, no. 16 : 4233. (2021).","DOI":"10.3390\/cancers13164233"},{"key":"79688_CR38","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. Identifying FL11 subtype by characterizing tumor immune microenvironment in prostate adenocarcinoma via Chou\u2019s 5-steps rule. Genomics 112, no. 2 : 1500\u20131515. (2020).","DOI":"10.1016\/j.ygeno.2019.08.021"},{"key":"79688_CR39","doi-asserted-by":"crossref","unstructured":"Kaur, S., Najm, M. Z., Khan, M. A., Akhter, N. & Shingatgeri, V. M. Mudra Sikenis, Sadaf, and Abdulaziz A. Aloliqi. Drug-resistant breast cancer: Dwelling the hippo pathway to manage the treatment. Breast Cancer: Targets Therapy : 691\u2013700. (2021).","DOI":"10.2147\/BCTT.S343329"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79688-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:04:38Z","timestamp":1732194278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79688-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79688-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28857"}}